You just read:

Regeneron and Sanofi Announce First Approval of Kevzara™ (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients by Health Canada

News provided by

Regeneron Pharmaceuticals, Inc.

Feb 01, 2017, 01:00 ET